The semaglutide family of drugs ... “Most people come to me for weight loss, and I’ve seen that if they don’t take the standard dose, then they don’t lose weight.” Where she does see micro dosing work ...

More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.

Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...

The Food and Drug Administration allows for licensed compounding pharmacies to make copies of certain drugs in short supply, and that has included semaglutide and tirzepatide, the main ingredients in ...

Modern medical innovations continue to transform treatment approaches for chronic conditions, and Ozempic stands at the ...

Ethics Board Approval Granted for Lexaria Receives Ethics Board Approval for 12-Week Phase 1b DehydraTECH GLP-1 Study in ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

Scholars discuss the regulatory landscape surrounding GLP-1 drugs and dietary supplements.

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

GLP-1RA prescription trends, real-world effectiveness, and predictors for access and rationing were highlighted at ...

Popular semaglutide-based drugs used for weight loss may reduce chronic and acute pain, which could make them a promising ...